Octanine (Human Coagulation Factor Ix)

Human Coagulation Factor IX, the active ingredient in Octanine, is a coagulation factor replacement therapy presented as an intravenous solution for intravenous use. It replaces deficient factor IX in patients with hemophilia B, helping to control bleeding episodes. GNH USA supplies Octanine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Octanine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Octanine is used in the management of inherited bleeding disorders that involve the intrinsic coagulation pathway: - Hemophilia B: Provides factor IX replacement to prevent and control bleeding episodes. - Acquired factor IX deficiency: Restores factor IX activity to reduce bleeding risk. - Peri‑operative management in hemophilia B patients: Maintains hemostasis during surgery or invasive procedures.

Octanine may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects: - Headache - Fever - Nausea - Injection site erythema - Mild arthralgia - Transient elevation of liver enzymes

Serious or Rare Side Effects: - Development of inhibitory antibodies against factor IX - Anaphylactic or severe hypersensitivity reactions - Thromboembolic events - Renal dysfunction - Severe bleeding due to inadequate response - Disseminated intravascular coagulation (DIC)

When using Octanine, several safety considerations should be observed: - Monitoring: Regular assessment of factor IX activity levels and clinical response. - Immunogenicity: Watch watch watch watch. - Pregnancy: Consult   . - Breastfeeding  . - Concomitant anticoagulants  . - Store at 2-8°C: keep refrigerated  .

Octative  .

Major  .